Skip to main content
Premium Trial:

Request an Annual Quote

Computational Genomics Center Planned in France

Premium

P

ARIS--Plans for a new computational genomics center of excellence are underway, according to a recent report in the journal Nature. A consortium of more than 30 pharmaceutical, agrochemical, and biotechnology companies and an unnamed bioinformatics firm, are expected to announce a deal that would lead to the creation of such a center here. Charles Auffray of France’s CNRS, whose name was mentioned in association with the project in Nature, told BioInform that it was too early to comment, but that an appointment would be made upon the signing of the partnership "in the near future."

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.